,72 However, clinically relevant data on the role of CDH2 in microenvironment-mediated cancer proliferation and therapy resistance in acute leukemia have until now been scarce, as has the means of clinically targeting this via low toxic agents. The gene discussed is CDH2; the disease is cancer.